chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Cough, Nausea
Clinical narrative: Severe back aches and pain; cough; chills; stomach nausea; This is a spontaneous report received from a Consumer or other non HCP.  A 62-year-old female patient (not pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 04Jun2025 at 11:30 as dose 1, single (Batch/Lot number: unknown) at the age of 62 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "Covid in January 2023 with some continuing symptoms.", start date: Jan2023 (ongoing), notes: Covid in January 2023 with some continuing symptoms. The patient took concomitant medications. The following information was reported: BACK PAIN (non-serious) with onset 05Jun2025, outcome "not recovered", described as "Severe back aches and pain"; CHILLS (non-serious) with onset 05Jun2025, outcome "not recovered"; COUGH (non-serious) with onset 05Jun2025, outcome "not recovered"; NAUSEA (non-serious) with onset 05Jun2025, outcome "not recovered", described as "stomach nausea". Therapeutic measures were not taken as a result of back pain, cough, chills, nausea.  Additional information: The patient was received unspecified concomitant on 03Mar2025 and no allergies were reported. The patient received vaccine on upper arm. The patient did not receive any other vaccines on the same date as the vaccine(s). The patient did not receive any other vaccines within 4 weeks PRIOR to the vaccine(s). The patient was taking other medications within 2 weeks of the event starting. Reported Event: Severe back aches and pain, chills, stomach nausea, cough (which continues thru this reporting date).  The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a consumer, Program ID.  An elderly female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), as dose number unknown, single) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Paxlovid for COVID-19 treatment. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset Jun2025, outcome "unknown", COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The event "covid-19" required physician office visit. The patient was on the line, she wanted to share her experience with previous use of Pfizer. She had COVID again after nirmatrelvir/ritonavir (PAXLOVID). The patient and her husband got COVID again despite all the vaccination and everything. They are senior citizens, so now they wanted to take Paxlovid again, at least her husband. The patient didn't know if she was going to take it and now of course it's no longer paid for and there is outrageous cost because it's listing as it might cost an amount to make but it's listed number of dollars and then the insurance is not paying that much. The patient and her husband took all the vaccination and again came positive for COVID but clarified that the patient did not have them all (only her husband had it all). She had been called for them, but did not have the last one. When clarified if the vaccines are of Pfizer, the patient confirmed they had some of the vaccines that were mixed, Pfizer and Moderna. After asking for confirmation if both the patient and her husband have COVID and were prescribed Paxlovid, the patient confirmed but thinks she was not going to take it because she was already in her fifth day, and she was not as sick.  The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500126535 Same reporter, product, and event; different patient;US-PFIZER INC-202500126535 same reporter/product/event; different patient;
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: came positive for COVID; My husband took all of them; came positive for COVID; My husband took all of them; This is a spontaneous report received from a Consumer or other non HCP, Program ID.  An elderly male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Paxlovid, start date: 2024, stop date: 2024, for COVID-19 treatment. Vaccination history included: Bnt162b2 (some of the vaccines were mixed, Pfizer (Unspecified Vaccine) and Moderna (Unspecified Vaccine)), for Covid-19 Immunization; Moderna (some of the vaccines were mixed, Pfizer (Unspecified Vaccine) and Moderna (Unspecified Vaccine)), for Covid-19 Immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2025, outcome "unknown" and all described as "came positive for COVID; My husband took all of them". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2025) Positive.  Clinical course: Patient is in his 1st or 2nd day of being sick.   The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500126534 same reporter/product/event; different patient; US-PFIZER INC-202500126534 Same reporter, product, and event; different patient;
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report received from a consumer, Program ID.  A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm".  Additional Information: The patient had a barely sore arm after getting the COVID-19 vaccine.  No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Sex: F
Vaccine: RSV
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: swollen & sore arm; swollen & sore arm; This is a spontaneous report received from a Consumer or other non HCP,.  An elderly female patient received rsv vaccine prot.subunit pref 2v (RSV VACCINE PROT.SUBUNIT PREF 2V), in 2024 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), PERIPHERAL SWELLING (non-serious), outcome "unknown" and all described as "swollen & sore arm". Additional information: Patient had the RSV vaccine last fall. Patient experienced a swollen & sore arm for more than a week after.  No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease
Clinical narrative: COPD; This is a spontaneous report received from a Consumer or other non HCP, Program ID.  A patient (age and gender not provided) received BNT162b2 (BNT162B2 NOS), in May2024 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Primary immunization series complete), for COVID-19 immunization. The following information was reported: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (non-serious), outcome "unknown", described as "COPD". Additional information: During an inbound call with general vaccine questions, the patient stated, "I'm curious about getting a COVID vaccine. Initially, when they first came out, I took nothing but Pfizer, and now-the last time I've had a vaccine was May of 2024....I have COPD, so I'm sort of in a position to really want to make sure I've got myself covered with booster protection."   The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.
Sex: M
Vaccine: RAB
Symptoms: Chest discomfort
Clinical narrative: tightness of chest with breathing; Initial information received on 20-Jun-2025 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves an unknown age male patient who had tightness of chest with breathing after receiving Rabies (HDC) vaccine [IMOVAX Rabies].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 12-Jun-2025, the patient received an unknown dose of suspect Rabies (HDC) vaccine Powder and solvent for suspension for injection (lot Y1A86P1) (strength and expiry date-unknown). On 15-Jun-2025 he also received an unknown dose of vaccine  On 19-Jun-2025 he also received an unknown dose of vaccine all via unknown route in unknown administration site for prophylactic vaccination (Immunisation).  On an unknown date the patient developed tightness of chest with breathing (chest discomfort) (unknown latency).  Reportedly- Rabies wanting to know if his vaccine he received has a recall due to seeing a recall from 2004.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Not Recovered / Not Resolved for the event.
Vaccine: YF
Symptoms: No adverse event, Wrong product administered
Clinical narrative: patient needed to be revaccinated for YF VAX when it was injected intramuscular instead of subcutaneous with no adverse event; Initial information received on 23-Jun-2025 regarding an unsolicited valid  non-serious case received from a pharmacist.  This case involves an unknown age and unknown gender patient who received Yellow fever vaccine - [YF-VAX] intramuscular instead of subcutaneous with no adverse event.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of 0.5ml of suspect Yellow fever vaccine - Solution for injection standard strength, frequency-once (lot number and expiry date-unknown) via intramuscular route in unknown administration site for Immunization instead of subcutaneous with no adverse event (incorrect route of product administration) (latency-same day).  Information on the batch number was requested corresponding to the one at time of event occurrence.  Action taken was not applicable.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Vaccine: HIBV
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired ACTHIB was given with no reported adverse event; Initial information received on 23-Jun-2025 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves Infant patient with unknown gender who was administered to expired HIB (PRP/T) Vaccine [ACT-HIB] was given with no reported adverse event.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 23-Jun-2025, the patient received expired 0.5mL of suspect HIB (PRP/T) Vaccine, Powder and solvent for solution for injection (lot UK092AB, strength standard, frequency once and expiry date not reported) via unknown route in unknown administration site for Immunization (expired product administered) (latency same day).  Reportedly, they wanted to know if it has to be re-administered.   Action taken was not applicable.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 51.0
Sex: F
Vaccine: PNC20
Symptoms: Peripheral swelling, Pruritus, Skin tightness, Skin warm
Clinical narrative: Swollen arm, tight skin, hot to touch, itching
Age: 73.0
Sex: F
Vaccine: TDAP
Symptoms: Mobility decreased, Periarthritis, Spinal pain, X-ray limb
Clinical narrative: Pain and decreased mobility in shoulder that started to intensify 7 to 14 days post injection.. Received shot of cortisone on 6/24/25 which is today.
Age: 26.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site bruising, Injection site urticaria, Pain in extremity, Sleep disorder
Clinical narrative: 26-year-old female, with no past medical history of vaccine reactions, experienced a reaction following a Tdap vaccine administered on Friday 06/20/25. The next day, she reported pain in her left arm, which disrupted her sleep. The pain was initially severe but has since improved, although it remains present. She also experienced itching and a bruise at the injection site. Patient has never had a reaction to vaccines before and has never received a tetanus vaccine before this. She took Tylenol 500 mg, which provided temporary relief, but symptoms returned after 10 hours. No Benadryl was taken. Additionally, no reported anaphylactic symptoms.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Circumstance or information capable of leading to medication error, Injection site erythema, Injection site pain
Clinical narrative: Pt received e all vaccines appropriately and getting booster  #5 DTaP and IPV #4 via Kinrix., the vaccine was given  in distal humeral area, with 1in 23 g needle, yet unsure how far down needle went and likely not into muscle.  Pt had erythema noted over injection site the next day which progressed for another day and then as of date erythema is decreasing. Pt did not  have any fever. had soreness at site.
Age: 36.0
Sex: F
Vaccine: MMRV
Symptoms: Underdose, Wrong product administered
Clinical narrative: Patient was given wrong Vaccine. Patient came in to get MMR vaccine, but the staff accidentally administered MMRV peds vaccine.
Age: 39.0
Sex: F
Vaccine: MENB, MMR
Symptoms: Fatigue, Nausea
Clinical narrative: Tiredness, nausea.
Age: 38.0
Sex: F
Vaccine: TDAP
Symptoms: Chest pain, Dyspnoea, Exposure during pregnancy, Heart rate increased
Clinical narrative: vaccine given at 3:44PM and patient complained of shortness of breath, chest pains and rapid heart rate, this LVN rechecked vitals signs and reported to provider at 3:45PM, provider did reevaluation at 3:55PM, patient is 31 weeks and 4 days gestation, estimated date of delivery is 08/22/025
Age: 16.0
Sex: M
Vaccine: HPV9, MENB, MNQ
Symptoms: Fall, Feeling abnormal, Pallor, Syncope, Tongue biting
Clinical narrative: 16 year old male fainted after reciving vaccines,  and fell on the floor face first. bit his tongue. blood pressure 99/64 pulse 55, Patient awake and oriented, looks pale and feels daze.
Age: 74.0
Sex: F
Vaccine: RSV
Symptoms: Limb mass
Clinical narrative: Noticed she had about a 1/4-1/2 inch bump on her right wrist. It wasn't painful, but only appeared this afternoon. She put ice on it, which did appear to help. She described it as being like a ""burst blood vessel."
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Contusion, Eye pain, Headache, Influenza like illness
Clinical narrative: Flu like symptoms, bruising of legs/arms, and severe headache/ocular pain
Age: 38.0
Sex: F
Vaccine: HEPA
Symptoms: Dizziness, Hyperhidrosis, Nausea, Pallor
Clinical narrative: Patient received vaccine and sat in waiting room after.  She became very pale, dizzy, sweaty and nauseated.  Called 911 but patient stated she did not want to ride in an ambulance.  Her eyes looked dilated and her vision was blurry.  She said she felt a "ball in her throat".  She was able to speak and swallow and was given orange juice and a glucose tablet to make sure her sugar was not low.  An  Epi-pen was available for use if necessary.   Patient was in waiting  room for approximately an hour.   As she was coming around, she mentioned pain in her lower abdomen.   Her father, who was with her, stated he was going to take her to the ER to get checked out.  I encouraged her to be seen even though  she was improving  to rule out any other complications.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Sustained increased resting heart rate starting after administration. Increased ~15 bpm over a few months and has remained increased.
Age: 63.0
Sex: F
Vaccine: COVID19, HEPA, PNC20
Symptoms: Erythema, Peripheral swelling
Clinical narrative: red arm and a little swollen (recommended Benadryl and monitor injection site)
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Angioedema, Dyspnoea, Urticaria
Clinical narrative: Patient experienced anaphylaxis with angioedema, hives, and shortness of breath. They were given epinephrine, Benadryl, and prednisone.
Sex: M
Vaccine: HEP
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Received Heplisav-B first dose received on 1/29/2025, then patient received Engerix on 2/17/2025, and then received Heplisav-B on 2/26/2025.; Received Heplisav-B first dose received on 1/29/2025, then patient received Engerix on 2/17/2025, and then received Heplisav-B on 2/26/2025.; Initial report received on 27-May-2025.   A medical assistant reported that a male patient received the first dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization, then received ENGERIX-B, and then received the second dose of HEPLISAV-B four weeks after the first. No medical history or concomitant medications were reported.    On 29-Jan-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot #,expiration date, NDC #, route, and site not available)].     On 17-Feb-2025, 19 days after receiving dose 1 of HEPLISAV-B, the patient received a dose of a hepatitis b vaccine [ENGERIX-B (lot #, expiration date, NDC #, route, and site not available)].  On 26-Feb-2025, 28 days after receiving dose 1 of HEPLISAV-B, the patient received dose 2 of a HEPLISAV-B (lot #, expiration date, NDC #).   No adverse reactions were reported.      Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Vaccine: HEP
Symptoms: Interchange of vaccine products
Clinical narrative: First Dose Received HEPLISAV-B and Second Dose ENGERIX-B; Initial report received on 04-Jun-2025.  A nurse reported that a patient (age and gender not reported) received HEPLISAV-B (hepatitis B vaccine) as the first dose of hepatitis B immunization and the second dose received was ENGERIX-B.   No medical history or concomitant medications were reported.  On an unknown date, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)].   On an unknown date, after having been vaccinated with HEPLISAV-B, the patient received the second dose of hepatitis B vaccine [ENGERIX-B (lot number and expiration date not reported)].    No other information was available.  Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Vaccine: UNK, VARCEL
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No symptomatic events were reported. No additional AE; MMR II and VARIVAX were administered to a patient when they did not need to receive it.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender.   The patient's medical history, concurrent and concomitant therapies were not reported.   On 19-JUN-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) injection, lot #Z004454 [which has been verified to be valid lot number for Varicella Virus Vaccine Live (Oka-Merck)], expiration date reported and upon internal validation establish as 13-FEB-2027 and with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) injection, lot #Y015022 [which has been verified to be valid lot number for Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live], expiration date reported and upon internal validation establish as 05-SEP-2026. The vaccines were reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported) and were administered for prophylaxis (strength, dosage, route and anatomical site of administration were not reported).   It was reported that the vaccines were administered although the patient did not need to receive them (Wrong product administered). No symptomatic events were reported (No adverse event).
Age: 43.0
Sex: F
Vaccine: RAB
Symptoms: Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: Period began 12 days early (on day 17 of her cycle) and was heavy. Patient's cycle has been irregular since with the next cycle beginning 20 days later. This is outside of the norm for this patient.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, PNC20, RV5
Symptoms: Cyanosis, Injection site reaction, Vaccine positive rechallenge
Clinical narrative: Both legs (thighs down to feet) turned blue at daycare the day after the 6 month old vaccines as well as the day after the 4 month vaccines. Pulses were still normal, patient was still moving all extremities normally, and it self-resolved within 2 hours. No swelling or pain or erythema at the injection sites.
Age: 72.0
Sex: M
Vaccine: RSV
Symptoms: Extra dose administered
Clinical narrative: Not exactly an adverse event. Patient received the RSV vaccine and they had already received it a few months back.
Age: 17.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Dyskinesia, Loss of consciousness, Muscle contracture
Clinical narrative: Gave patient menquadfi in  Rt deltoid then  gave Men B in Lt deltoid when patient started passing out  I started fanning patient and mom grabbed wet paper towel  and placed on forehead patient then started jerking all over  with hands contracting  I opened clinic  door and called for help  other nurses came we raised foot of chair  I  ran and got two bite size kit kats patient ate after coming too  drank apple juice x2  and crackers  took blood pressure 107/73   and blood sugar 93.  RN Supervisor came down and talked to patients mom. Patient alert and oriented approximately 40 seconds  after passing out started
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Contusion, Pain in extremity, Rash, Rash erythematous
Clinical narrative: Rash to left side of her neck/chest. It is intermittent since 2021. Has tried Eucerin, Sarna which helps a little but it doesnt get it to completely go away. When it flares it lasts for 3 weeks then goes away for 1-2 weeks. The more she remembers to put the sarna on the better it is. Gets anxious and it flares the rash. Has a purple/red undertone  to it. Daughter says almost like purpura but not that intense. No real crusting drainage or bleeding to it. Tried triamcinolone cream and it didnt help  Historically sees a hematoma/bruising to R outer ankle or L inner ankle. No known injuries over the years. SIL feels like it looks like pooling. No swelling. No pain. lasts a couple weeks too. Has not seen it anywhere else. No supplements that increase her
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Sensory disturbance
Clinical narrative: Rash to left side of her neck/chest. It is intermittent since 2021. Has tried Eucerin, Sarna which helps a little but it doesnt get it to completely go away. When it flares it lasts for 3 weeks then goes away for 1-2 weeks. The more she remembers to put the sarna on the better it is. Gets anxious and it flares the rash. Has a purple/red undertone  to it. Daughter says almost like purpura but not that intense. No real crusting drainage or bleeding to it. Tried triamcinolone cream and it didnt help  Historically sees a hematoma/bruising to R outer ankle or L inner ankle. No known injuries over the years. SIL feels like it looks like pooling. No swelling. No pain. lasts a couple weeks too. Has not seen it anywhere else. No supplements that increase her
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Extra dose administered
Clinical narrative: The state record did not indicate any other dose of Varicella. The provider had the medical assistant administer an extra dose of varicella because she thought the series was not complete. The previous varicella was not on the state record but has now been added and corrected.
Age: 33.0
Sex: F
Vaccine: HEPA
Symptoms: Asthenia, Dizziness, Hyperhidrosis, Nausea
Clinical narrative: Within 5 minutes of vaccine, pt became extremely nauseated, diaphoretic, dizzy, and weak.  Symptoms lasted for 30 minutes.  Was treated with supportive care.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Depression, Suicidal ideation
Clinical narrative: None at the time
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Autopsy, Cardiac arrest, Death, Gastrooesophageal reflux disease, Granuloma
Clinical narrative: Patient suffered cardiac arrest on 10/23/23 and did not survive.  Prior to his death he worked in the (redacted) state during and after 911 attacks
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Liver sarcoidosis, Myocarditis, Pulmonary sarcoidosis, Sarcoidosis of lymph node, Splenic sarcoidosis
Clinical narrative: Patient suffered cardiac arrest on 10/23/23 and did not survive.  Prior to his death he worked in the (redacted) state during and after 911 attacks
Age: 53.0
Sex: F
Vaccine: CHOL, DTAP, TYP
Symptoms: Dyspnoea, Lung disorder, Rash, Rash vesicular, Tinnitus
Clinical narrative: 5 days after vaccine both me and my husband have blister like rash all over the body. More concentrated  on belly  but down the legs back and feet. I personally have been in the ER twice once on 6/20/25 for rash and difficulty breathing. Steroids and benedryl was given the 1st time. Repeat ER visit 6/22/25 given Epi , & Steroids. Found spots on my lungs unclear why.
Age: 1.08
Sex: F
Vaccine: DTPPVHBHPB
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: Adverse Event(s): On May 20, 2025, while I was present with my child, a potential vaccine administration error occurred. I was informed by staff member that the vaccine being administered was Vaxelis, despite previous documentation from an April 29 visit indicating my child was due for the Hepatitis A (Hep A) vaccine. I voiced this concern directly before administration, but provider proceeded with the vaccination regardless.  Treatment: A vaccine was administered?initial documentation identified it as Vaxelis. This was later revised to show that Hep A had been given, but the patient portal still lists Vaxelis. No immediate physical symptoms or adverse reactions were observed following the vaccination.  Outcome(s): The conflicting verbal and written information created significant confusion and concern about the accuracy of medical records and the vaccine received. While no physical symptoms have been reported to date, the documentation conflict and lack of confirmation procedures present a serious risk to patient safety and future care decisions. The issue remains unresolved in the digital health chart.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Fall, Loss of consciousness
Clinical narrative: AFTER GETTING THE 2ND  SHOT, PT PASSED OUT FORWARD OFF THE EXAM TABLE.
Age: 33.0
Sex: M
Vaccine: PNC21
Symptoms: Headache, Immediate post-injection reaction, Injection site haemorrhage, Injection site pain, Musculoskeletal stiffness
Clinical narrative: Vaccine injected into upper right arm and into a vein. The site of injection started bleeding immediately after needle was released from skin. I stated to the employee that she injected the vaccine into vein. She denied it and stating that there is only muscle at the site of injection. Symptoms that I'm currently experiencing are headache, arm stiffness, pain at the site of injection, and swelling. *CURRENTLY ON MY WAY TO EMERGENCY ROOM*
Age: 33.0
Sex: M
Vaccine: PNC21
Symptoms: Swelling
Clinical narrative: Vaccine injected into upper right arm and into a vein. The site of injection started bleeding immediately after needle was released from skin. I stated to the employee that she injected the vaccine into vein. She denied it and stating that there is only muscle at the site of injection. Symptoms that I'm currently experiencing are headache, arm stiffness, pain at the site of injection, and swelling. *CURRENTLY ON MY WAY TO EMERGENCY ROOM*
Age: 30.0
Sex: M
Vaccine: TDAP
Symptoms: Extra dose administered
Clinical narrative: Pt received dose of Boostrix after having had one dose administered 09/15/2024 at pharmacy. Our system indicated he was due for a booster and database identified last vaccine was 2006. No symptoms as of today from vaccine 6/23/25
Age: 59.0
Sex: M
Vaccine: TDAP
Symptoms: Joint swelling, Peripheral swelling, Skin warm, Tenderness
Clinical narrative: The injection Site is not inflamed or irritated. Donor's left hand/wrist is swollen, red, and painful to touch. Donor's hand and wrist is also warm to the touch.  Counseled donor to seek outside care.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: Was seen at urgent care and hospital for chest discomfort.
Age: 62.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Acute myeloid leukaemia, Cardiac discomfort, Death, Fatigue, Heart rate increased
Clinical narrative: 2 weeks after 2nd shot April 14) of Moderna Covid 19 - patient began feeling extremely fatigued.  Scheduled Televisit with physician and told to check back of tonsils for white spots.  Did so and told possibly Strep.   Antibiotics given.    Fatigue and increased heart rate continued.  On May 16, 2021, Patient said heart felt that was going to explode.  Went to ER and then diagnosed with Acute Myeloid Leukemia (AML) w/ FLT3 marker.   Patient was perfectly healthy prior to COVID 19 shot.  Diet considered of daily amounts of fruits, vegetables (greens) and meats.  Very healthy/balanced.  He exercised daily - resistance training and cardio.  Never  sick except for a cold.  No history of cancer in family patient was required to take the vaccine due to his company mandate and visiting healthcare facilities.   Again, a healthy individual, exceptional diet - minimal processed foods, exercised daily, not overweight and maintain a disciplined routine.  It seems more than a coincidence   the change in his health was only a couple weeks after the 2nd injection (4/14/21) of the Moderna vaccine.  He had battled this diagnosis for 4 years in/out of remission 3 times.  Ultimately passing due to complications of some of the final preventative treatments.    Previous annual physicals were all good/normal.  Could this vaccine targeted a dormant AML gene?   Did it create the cancer.  Some consulted physicians said it is a possibility but would not know for years and that is ONLY if the data is being gathered.  We know of 3 other patients that were also very healthy within a 5-20 minute radius, also diagnosed with AML and at least 1 with the FLT 3 Marker during the same time frame.  Pfizer Vac in May/June 2022 ; Pfizer Booster in Sept 2022 and SPIKEVAX Oct. 2023.    I hope the CDC and other health agencies (physicians, hospitals, etc.). help with this data gathering with patience to improve patience mortality rates and not to cause cancer, chronic illnesses or death.  We only will know what we are willing to do a "deep dive", study, learn, open-minded to build upon the science that constantly evolves.  We need to do the research to build to confidence level in our vaccines.   I know I'm skeptical because of knowing my husband as a healthy man at 63 and the extreme change in health in a matter of a couple weeks.  We as a country did our best to get "something out there" for Covid - but it may cause harm to some.
Age: 0.17
Sex: M
Vaccine: DTAP, HIBV, PNC15, RV1, UNK
Symptoms: Choking, Cyanosis, Dyspnoea, Foaming at mouth, Seizure
Clinical narrative: Labored breathing, seizure like activity, convulsions, skin turned gray, lips and nails blue/purple, foaming out of mouth and choking. Went to physician on call, then ER. Was over a couple days.
Age: 0.17
Sex: M
Vaccine: DTAP, HIBV, PNC15, RV1, UNK
Symptoms: Seizure like phenomena, Skin discolouration
Clinical narrative: Labored breathing, seizure like activity, convulsions, skin turned gray, lips and nails blue/purple, foaming out of mouth and choking. Went to physician on call, then ER. Was over a couple days.
Age: 0.42
Sex: F
Vaccine: HIBV, PNC20
Symptoms: Circumoral swelling, Eye swelling, Rash
Clinical narrative: Patient started with a rash in the diaper area the next day and then the rash spread to her torso and back arms ands legs and then progressively got worse especially on her face- her eyes were swollen and around her mouth,  this all happened over the span of 8 days with the worse on the morning of day 8.  Prednisolone was prescribed and given x2 doses in 48 hours. The rash began to subside.
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: 6/23/25: SMALL RED AREA AROUND SITE SMALL AMOUNT SWELLING  6/24/25 REDNESS AROUND VACCINE SITE INCREASED, SWELLING AND TENDERNESS INCREASED 6/25/25 SLIGHTLY LARGER AREA OF REDNESS AROUND VACCINE SITE, 2" CIRCUMFERENCE NOW, PAINFUL, TENDER. CALLED PCP 10:25 TODAY TO NOTIFY AND RTC FOR EVALUATION.
Age: 53.0
Sex: F
Vaccine: MMR
Symptoms: Gastroenteritis
Clinical narrative: Severe acute gastroenteritis symptoms without any signs of viral or bacterial cause
Age: 11.0
Sex: M
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Patient received a Bexsero meningococcal B vaccine when he is not of age for it; he was supposed to receive a Menveo meningococcal 4 vaccine.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MNQ
Symptoms: Antinuclear antibody negative, Arthralgia, Body temperature increased, Borrelia test negative, C-reactive protein normal
Clinical narrative: patient reports temp of 103 8 hours after injection with headache, myalgias and vomited that lasted for 48 hours. 6 days following injection patient had polyarthritis of elbows, knees, ankles and wrists with swelling of finger and toes. Swelling resolved 48 hours later and 15 days later patient still complains of wrist and ankle tenderness.  - Blood work done by patients' father (a pediatrician)  during episode to rule out rheumatoid process and all labs were normal
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MNQ
Symptoms: Full blood count normal, Headache, Myalgia, Peripheral swelling, Polyarthritis
Clinical narrative: patient reports temp of 103 8 hours after injection with headache, myalgias and vomited that lasted for 48 hours. 6 days following injection patient had polyarthritis of elbows, knees, ankles and wrists with swelling of finger and toes. Swelling resolved 48 hours later and 15 days later patient still complains of wrist and ankle tenderness.  - Blood work done by patients' father (a pediatrician)  during episode to rule out rheumatoid process and all labs were normal
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MNQ
Symptoms: Red blood cell sedimentation rate normal, Rheumatoid factor negative, Streptococcus test negative, Vomiting
Clinical narrative: patient reports temp of 103 8 hours after injection with headache, myalgias and vomited that lasted for 48 hours. 6 days following injection patient had polyarthritis of elbows, knees, ankles and wrists with swelling of finger and toes. Swelling resolved 48 hours later and 15 days later patient still complains of wrist and ankle tenderness.  - Blood work done by patients' father (a pediatrician)  during episode to rule out rheumatoid process and all labs were normal
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MNQ
Symptoms: Anti-cyclic citrullinated peptide antibody negative, Antinuclear antibody negative, C-reactive protein normal, Full blood count normal, Nausea
Clinical narrative: patient reports temp of 103 8 hours after injection with headache, myalgias and vomited that lasted for 48 hours. 6 days following injection patient had polyarthritis of elbows, knees, ankles and wrists with swelling of finger and toes. Swelling resolved 48 hours later and 15 days later patient still complains of wrist and ankle tenderness.  - Blood work done by patients' father (a pediatrician)  during episode to rule out rheumatoid process and all labs were normal
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MNQ
Symptoms: Polyarthritis, Pyrexia, Red blood cell sedimentation rate normal, Rheumatoid factor negative, Streptococcus test negative
Clinical narrative: patient reports temp of 103 8 hours after injection with headache, myalgias and vomited that lasted for 48 hours. 6 days following injection patient had polyarthritis of elbows, knees, ankles and wrists with swelling of finger and toes. Swelling resolved 48 hours later and 15 days later patient still complains of wrist and ankle tenderness.  - Blood work done by patients' father (a pediatrician)  during episode to rule out rheumatoid process and all labs were normal
Age: 3.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Dose inadvertently given at wrong time; This was child's 3rd dose of DTaP and IPV and child was 3 years and 9 months at time of administration.
Age: 13.0
Sex: M
Vaccine: MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Was given to child age 13 yr and 8 months, outside the recommended age range of maximum age 12 years and 11 months. No adverse reactions noted. No history of febrile seizures in family.
Age: 18.0
Vaccine: MENB
Symptoms: Injection site erythema, Injection site induration, Injection site urticaria
Clinical narrative: MOTHER CONTACTS THE NURSING DEPARTMENT ON 06/25/25 AND REFERS "MY DAUGHTER WAS VACCINATED ON THURSDAY AND SHE GOT RED HIVES AND BECAME HARD. HER INVESTIGATION WAS CARRIED OUT AND REFERS THE AREA: "WHERE SHE WAS VACCINATED." SHE LATER REFERRED "I TOOK HER TO THE HOSPITAL YESTERDAY."
Age: 0.67
Sex: M
Vaccine: RV5
Symptoms: Extra dose administered
Clinical narrative: 3rd dose of series given to patient 34 weeks of age.
Age: 68.0
Sex: F
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Dose two was given a month early.
Age: 52.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Oropharyngeal pain, Petechiae, Rash
Clinical narrative: 2 days after receiving vaccines, petechial rash appeared on lower extremities bilaterally. the next day he developed a rash on his arms. the next day developed sore throat and mild headache
Age: 0.58
Sex: M
Vaccine: DTPPVHBHPB, PNC20
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient was provided 2nd vaccine in series at wrong interval.
Age: 50.0
Sex: F
Vaccine: YF
Symptoms: Cough, Dyspnoea, Feeling abnormal, Mouth swelling
Clinical narrative: Patient walked in for yellow fever vaccine, technician entered details, reviewed patient VAR, and allergies, Patient stated she had idiopathic allergies and does not know what she is allergic to per her blood work from MD. Patient understood potential risk for reaction and wanted to proceed with vaccination for her trip (patient stated it is required for entry into the country) and stated she has an EpiPen. Patient received vaccine, was asked to wait a minimum of 15 minutes to monitor for adverse events. Approximately 5 minutes after receiving vaccine patient states her mouth feels swollen. I asked if she was having any difficulty breathing, she stated no. A few moments later when I checked in with her she requested Benadryl. I provided her with 50mg of Benadryl and continued to monitor for signs of anaphylaxis. Continued to monitor and informed patient she will need a driver to take her home after taking Benadryl. She contacted a family friend to come pick her up and another friend to drive her car home. I asked if anyone would be home to monitor her and she said her husband would be home at 5:30PM. I asked if her friend would be able to remain with her until her husband got home a to which she said yes. Shortly thereafter she stated her insides "feel weird". I asked if it could be anxiety related to which she stated she has a history of a panic attack 2 years ago. She was sitting in the lobby after taking Benadryl approximately 10 minutes later she became short of breath and began coughing. Code green was called. She appeared panicked and I asked if she was having trouble breathing she nodded. I asked if she would like me to administer EpiPen  she couldn't agree verbally to which she nodded yes. I administered EpiPen 0.3mg into her left thigh and patient continued coughing until EMT arrived. EMT brought a stretcher and took her to the emergency room.
Age: 0.33
Sex: M
Vaccine: DTAPIPV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pt was given a vaccine that is intended for ages 4-6. Pt is 4 months old.
Age: 22.0
Sex: M
Vaccine: MNQ
Symptoms: Abdominal pain upper, Blood test abnormal, Body temperature fluctuation, Chills, Computerised tomogram
Clinical narrative: administered IM on Left deltoid. recent meningitis vaccine 6/20/25 Reason:starting 6/21/25 saturday Fever/Chills/Bodyache/Nausea/Vomiting/diarrhea/stomach ache/ frequent urination.  Pt was seen at ER on Monday morning due to fluctuating temperature. - had blood test- state abn labs, urine sample and ct scan - advised to be admitted, was admitted and was discharge last night.  was advised to report to SHC  as of today: fever ( 102-103) // diarrhea - verbalized watery stool, had 6x today of diarrhea//  Vomiting x1 today//  stomachache since saturday - today same( not worst not better from onset )
Age: 22.0
Sex: M
Vaccine: MNQ
Symptoms: Diarrhoea, Nausea, Pain, Pollakiuria, Pyrexia
Clinical narrative: administered IM on Left deltoid. recent meningitis vaccine 6/20/25 Reason:starting 6/21/25 saturday Fever/Chills/Bodyache/Nausea/Vomiting/diarrhea/stomach ache/ frequent urination.  Pt was seen at ER on Monday morning due to fluctuating temperature. - had blood test- state abn labs, urine sample and ct scan - advised to be admitted, was admitted and was discharge last night.  was advised to report to SHC  as of today: fever ( 102-103) // diarrhea - verbalized watery stool, had 6x today of diarrhea//  Vomiting x1 today//  stomachache since saturday - today same( not worst not better from onset )
Age: 22.0
Sex: M
Vaccine: MNQ
Symptoms: Urine analysis, Vomiting
Clinical narrative: administered IM on Left deltoid. recent meningitis vaccine 6/20/25 Reason:starting 6/21/25 saturday Fever/Chills/Bodyache/Nausea/Vomiting/diarrhea/stomach ache/ frequent urination.  Pt was seen at ER on Monday morning due to fluctuating temperature. - had blood test- state abn labs, urine sample and ct scan - advised to be admitted, was admitted and was discharge last night.  was advised to report to SHC  as of today: fever ( 102-103) // diarrhea - verbalized watery stool, had 6x today of diarrhea//  Vomiting x1 today//  stomachache since saturday - today same( not worst not better from onset )
Age: 52.0
Sex: F
Vaccine: PNC20
Symptoms: Erythema, Fatigue, Hypersensitivity, Limb mass, Local reaction
Clinical narrative: Localized reaction to pneumococcal vaccine-symptoms started 1 hour after shot.  Shot was given on 5/30/25 at office visit for a routine physical, patient called the RN triage line to on 6/3/25 to report symptoms of increased redness, pain 10/10, body aches and fatigue Stated she felt feverish but had not taken her temp.   Skin on Left arm was hot, red with small fluid filled bumps forming. Patient reported that area was also itchy.  Was deposed to go to Urgent care to be seen.   She did so and was diagnosed with  focal reaction to recent pneumococcal vaccine.   The redness and swelling is due to focal inflammatory allergic response. Assessment/ Plan Diagnoses and associated orders for this visit:   Allergic reaction, initial encounter -     CREATINE KINASE; Future -     C-REACTIVE PROTEIN, INFLAMMATORY; Future -     famotidine (PEPCID) 40 mg oral Tablet; Take 1 Tablet (40 mg) by mouth in the morning and 1 Tablet (40 mg) in the evening. Do all this for 7 days. -     methylPREDNISolone (MEDROL DOSPACK) 4 mg oral Tablets, Dose Pack; Take 1-6 Tablets (4-24 mg) by mouth as directed for 6 days. Take per package instructions. -     triamcinolone acetonide (KENALOG) 0.1 % topical Cream; Apply to the affected area(s) as needed in the morning and as needed in the evening for rash.     Denies any trouble breathing no lip or tongue swelling no dizziness no weakness.   Focal reaction to recent pneumococcal vaccine pictures uploaded into my chart I think the redness and swelling is from focal inflammatory allergic response   Treating with above medications discussed I did not think this was cellulitic but if symptoms not improving with above treatment or worsening to return to clinic they are agreeable with plan       attempted to reach out to patient x3 for follow up and left message to call back..  no return call. to date.
Age: 52.0
Sex: F
Vaccine: PNC20
Symptoms: Pain, Pruritus, Pyrexia, Rash, Skin warm
Clinical narrative: Localized reaction to pneumococcal vaccine-symptoms started 1 hour after shot.  Shot was given on 5/30/25 at office visit for a routine physical, patient called the RN triage line to on 6/3/25 to report symptoms of increased redness, pain 10/10, body aches and fatigue Stated she felt feverish but had not taken her temp.   Skin on Left arm was hot, red with small fluid filled bumps forming. Patient reported that area was also itchy.  Was deposed to go to Urgent care to be seen.   She did so and was diagnosed with  focal reaction to recent pneumococcal vaccine.   The redness and swelling is due to focal inflammatory allergic response. Assessment/ Plan Diagnoses and associated orders for this visit:   Allergic reaction, initial encounter -     CREATINE KINASE; Future -     C-REACTIVE PROTEIN, INFLAMMATORY; Future -     famotidine (PEPCID) 40 mg oral Tablet; Take 1 Tablet (40 mg) by mouth in the morning and 1 Tablet (40 mg) in the evening. Do all this for 7 days. -     methylPREDNISolone (MEDROL DOSPACK) 4 mg oral Tablets, Dose Pack; Take 1-6 Tablets (4-24 mg) by mouth as directed for 6 days. Take per package instructions. -     triamcinolone acetonide (KENALOG) 0.1 % topical Cream; Apply to the affected area(s) as needed in the morning and as needed in the evening for rash.     Denies any trouble breathing no lip or tongue swelling no dizziness no weakness.   Focal reaction to recent pneumococcal vaccine pictures uploaded into my chart I think the redness and swelling is from focal inflammatory allergic response   Treating with above medications discussed I did not think this was cellulitic but if symptoms not improving with above treatment or worsening to return to clinic they are agreeable with plan       attempted to reach out to patient x3 for follow up and left message to call back..  no return call. to date.
Age: 0.5
Sex: M
Vaccine: DTAP
Symptoms: Expired product administered
Clinical narrative: Administered expired DTap, Mother notified, no symptoms reported.  Will follow up. Return to clinic in 2 weeks for repeat Dtap vaccine.
Age: 70.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Contusion
Clinical narrative: BRUISING/HEMATOMA FROM DELTOID TO BICEP BRACHII
Age: 64.0
Sex: M
Vaccine: PNC21
Symptoms: Pain, Pyrexia
Clinical narrative: Patient had high fever, chills, fatigue and body aches starting 3 hours after the vaccine administration and has taken Tylenol and Motrin for fever and body aches which partially resolved the symptoms. Continues to have mild symptoms 24 hours later